Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Common Cancer Gene Suppressed

By Biotechdaily staff writers
Posted on 23 May 2005
By studying laboratory mice with skin cancer, scientists have found a way to suppress a mutant gene called Ras, which is found in up to 30% of human tumors.

Ras is a cancer-causing gene, also known as an oncogene; normal copies of this gene are important in the cell-signaling process. More...
However, when mutated, Ras becomes an oncogene and can trigger the growth of tumors in the lung, colon, pancreas, as well as leukemia and thyroid cancer.

Efforts to inhibit activated Ras has had little success to date. However, researchers at the Huntsman Cancer Institute (Salt Lake City, UT, USA) reported that they have found an enzyme that, when inhibited, seems to reduce the incidence of Ras-induced tumors in mice. They published their findings in the May 9, 2005, online early edition of the Journal of the Proceedings of the [U.S.] National Academy of Sciences.

Matthew K. Topham, M.D., assistant professor of internal medicine at the University of Utah School of Medicine (Salt Lake City, UT, USA; www.utah.edu) and lead investigator on the study, explained that the researchers had initially been evaluating a group of enzymes that control the function of the Ras gene. These enzymes, called diacylglycerol kinases (DGKs), are implicated in tumor growth.

"When we began our investigation using a type of DGK, called DGK iota, we thought that its absence would cause more tumors to develop, as has happened with other DGKs we have tested. This time, though, when we tested mice with an activated Ras gene, but an absent DGK iota gene, the number of tumors was significantly reduced,” Dr. Topham remarked. "This result is interesting because it happened when the Ras gene was activated. The implication is that a drug therapy could be developed to reduce tumors caused by Ras without significant side effects.”

The investigators used mice that were bred to have a highly expressed mutant form of the Ras oncogene. Earlier studies showed that these mice were very prone to tumors. For the new study, the group of scientists removed the DGK iota gene in the mice and discovered they developed a small number of tumors, whereas mice with an intact DGK iota gene and an activated Ras gene showed considerably more tumor activity. Dr. Topham said his team will now more closely evaluate the process behind how DGK iota works to inhibit tumor formation.




Related Links:
Huntsman Cancer Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Gold Member
Serum Indices Control
Acusera Serum Indices Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.